Research programme: G protein-coupled receptor antagonists - TransTech Pharma
Alternative Names: GPCR antagonists - TransTech; Pain therapeutics - TransTechLatest Information Update: 21 Sep 2010
At a glance
- Originator TransTech Pharma
- Class
- Mechanism of Action G protein-coupled receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Neuropathic pain
Most Recent Events
- 21 Sep 2010 Discontinued - Preclinical for Neuropathic pain in USA (unspecified route)
- 20 May 2005 The programme is available for licensing (http://www.ttpharma.com)
- 08 Jul 2004 Preclinical trials in Neuropathic pain in USA (unspecified route)